Cargando…

Cripto-1 as a novel therapeutic target for triple negative breast cancer

Triple-negative breast cancer (TNBC) presents the poorest prognosis among the breast cancer subtypes and no current standard therapy. Here, we performed an in-depth molecular analysis of a mouse model that establishes spontaneous lung metastasis from JygMC(A) cells. These primary tumors resembled th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castro, Nadia P., Fedorova-Abrams, Natalie D., Merchant, Anand S., Rangel, Maria Cristina, Nagaoka, Tadahiro, Karasawa, Hideaki, Klauzinska, Malgorzata, Hewitt, Stephen M., Biswas, Kajal, Sharan, Shyam K., Salomon, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494913/ https://www.ncbi.nlm.nih.gov/pubmed/26059540

Ejemplares similares

Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1
por: Watanabe, Kazuhide, et al.
Publicado: (2009)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
por: Rangel, Maria Cristina, et al.
Publicado: (2016)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

Expression and functional role of CRIPTO-1 in cutaneous melanoma
por: De Luca, A, et al.
Publicado: (2011)

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
por: Ishii, Hiroko, et al.
Publicado: (2021)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
por: Freeman, David W., et al.
Publicado: (2021)

Expression of cripto in Human Pancreatic Tumors
por: Tsutsumi, Masahiro, et al.
Publicado: (1994)

Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer
por: Francescangeli, F, et al.
Publicado: (2015)

Autoregulation and Heterogeneity in Expression of Human Cripto-1
por: Loying, Pojul, et al.
Publicado: (2015)

CRIPTO-1 Is Immunolocalized in the Syncytiotrophoblast of Ampullary Pregnancies
por: Cabar, Fábio Roberto, et al.
Publicado: (2022)

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017)

RAD52 S346X variant reduces breast cancer risk in BRCA2 mutation carriers
por: Biswas, Kajal, et al.
Publicado: (2020)

Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
por: Alam, Md Jahangir, et al.
Publicado: (2018)

Insights into the role of heat shock protein 72 to whole-body heat acclimation in humans
por: Amorim, Fabiano Trigueiro, et al.
Publicado: (2015)

Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers
por: Kozin, Sergey V., et al.
Publicado: (2017)

Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
por: Wu, Zhengrong, et al.
Publicado: (2009)

Cripto haploinsufficiency affects in vivo colon tumor development
por: GIORGIO, EMILIA, et al.
Publicado: (2014)

Clinical significance of cripto-1 expression in lung adenocarcinoma
por: Zhang, Hua, et al.
Publicado: (2017)

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer
por: Di Desidero, Teresa, et al.
Publicado: (2015)

Na(+)/H(+) exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells
por: Amith, Schammim Ray, et al.
Publicado: (2016)

Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy
por: Darb-Esfahani, Silvia, et al.
Publicado: (2016)

Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells
por: Hasegawa, Masanori, et al.
Publicado: (2016)

Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer
por: Iskit, Sedef, et al.
Publicado: (2016)

Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal Carcinomas
por: Kuniyasu, Hiroki, et al.
Publicado: (1991)

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
por: Gasparini, Pierluigi, et al.
Publicado: (2014)

Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
por: Bansal, Nidhi, et al.
Publicado: (2015)

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
por: Li, Xiao-shan, et al.
Publicado: (2019)

Human cytomegalovirus and Herpes Simplex type I virus can engage RNA polymerase I for transcription of immediate early genes
por: Kostopoulou, Ourania N., et al.
Publicado: (2017)

Pro-invasive properties of Snail1 are regulated by sumoylation in response to TGFβ stimulation in cancer
por: Gudey, Shyam Kumar, et al.
Publicado: (2017)

Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
por: Bandeira, Carla Letícia, et al.
Publicado: (2014)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi
por: Strizzi, Luigi, et al.
Publicado: (2016)

Cripto-1 vaccination elicits protective immunity against metastatic melanoma
por: Ligtenberg, M. A., et al.
Publicado: (2016)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
por: Liu, Qinghai, et al.
Publicado: (2009)

Peripheral Inflammation is Associated with Altered Substantia Nigra Activity and Psychomotor Slowing in Humans
por: Brydon, Lena, et al.
Publicado: (2008)

Chronic Activation of Corticotropin-Releasing Factor Type 2 Receptors Reveals a Key Role for 5-HT1A Receptor Responsiveness in Mediating Behavioral and Serotonergic Responses to Stressful Challenge
por: Neufeld-Cohen, Adi, et al.
Publicado: (2012)

Hostility and Cellular Aging in Men from the Whitehall II Cohort
por: Brydon, Lena, et al.
Publicado: (2012)

Regulation of Bim in Health and Disease
por: Sionov, Ronit Vogt, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8mc7aqauoed8nim49n3eke3doc